Thus, results from different studies suggest that at different time points, NF-L levels may be considered a measure of structural brain lesion, complementary to MRI (80) but in the late phase after stroke, the interpretation of elevated blood levels of NF-L should not be therefore limited to the extent of injury or neurodegeneration (79). This evidence concerns the gene NEFL and stroke disorder.